Veterinary Therapeutics Market Size, Share & Industry Analysis, By Product (Veterinary Drugs {Anti-infectives, Anti-inflammatory, & Parasiticides}, Veterinary Vaccines {Inactivated, Live Attenuated, & Recombinant}, and Medicated Feed Additives {Antimicrobials, Anticoccidials, Antiparasitics}), By Animal Type (Companion {Feline, Canine, & Avian} and Livestock {Poultry, Porcine, & Bovine}) By Route of Administration (Oral, Parenteral, Topical, & Aerosol), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI100138

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2025
2. Pipeline Analysis
3. Regulatory Scenario By Key Countries/ Region, 2025
4. Pricing Analysis
5. Pet Ownership Statistics, By Key Countries/ Region, 2025
6. Snapshot on the Novel & Upcoming Therapies
7. Overview of Treatment Plans for Different Animal Diseases
8. New Product Launches, By Key Players
9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
10. Impact of COVID-19 on the Global Veterinary Therapeutics Market
Global Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Zoetis Services LLC
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Merck Animal Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Elanco
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Boehringer Ingelheim International GmbH.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Ceva
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Vetoquinol
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Virbac
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Phibro Animal Health Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Panav Bio Tech.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2025
2. Pipeline Analysis
3. Regulatory Scenario By Key Countries/ Region, 2025
4. Pricing Analysis
5. Pet Ownership Statistics, By Key Countries/ Region, 2025
6. Snapshot on the Novel & Upcoming Therapies
7. Overview of Treatment Plans for Different Animal Diseases
8. New Product Launches, By Key Players
9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
10. Impact of COVID-19 on the Global Veterinary Therapeutics Market
Global Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Veterinary Drugs
    1. Anti-infectives
    2. Anti-inflammatory
    3. Parasiticides
    4. Others
  2. Veterinary Vaccines
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Medicated Feed Additives
    1. Antimicrobials
    2. Anti-coccidials
    3. Antiparasitics
    4. Others
2. Market Analysis, Insights and Forecast – By Animal Type
  1. Companion
    1. Feline
    2. Canine
    3. Avian
    4. Others
  2. Livestock
    1. Poultry
    2. Porcine
    3. Bovine
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
  4. Aerosol
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals
  2. Veterinary Clinics
  3. Pharmacies & Drug Stores
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Zoetis Services LLC
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Merck Animal Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Elanco
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Boehringer Ingelheim International GmbH.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Ceva
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Vetoquinol
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Virbac
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Phibro Animal Health Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Panav Bio Tech.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Veterinary Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Veterinary Therapeutics Market Value Share (%), by Product, 2025 & 2034

Figure 3: Global Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025 & 2034

Figure 4: Global Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 5: Global Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 6: Global Veterinary Therapeutics Market Value (USD billion), by Region, 2025 & 2034

Figure 7: North America Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034

Figure 8: North America Veterinary Therapeutics Market Value Share (%), by Product, 2025

Figure 9: North America Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034

Figure 10: North America Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025

Figure 11: North America Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 12: North America Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025

Figure 13: North America Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: North America Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 15: North America Veterinary Therapeutics Market Value (USD billion), By Country, 2025 & 2034

Figure 16: North America Veterinary Therapeutics Market Value Share (%), By Country, 2025

Figure 17: Europe Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034

Figure 18: Europe Veterinary Therapeutics Market Value Share (%), by Product, 2025

Figure 19: Europe Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034

Figure 20: Europe Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025

Figure 21: Europe Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 22: Europe Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025

Figure 23: Europe Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 24: Europe Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 25: Europe Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 26: Europe Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025

Figure 27: Asia Pacific Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034

Figure 28: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Product, 2025

Figure 29: Asia Pacific Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034

Figure 30: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025

Figure 31: Asia Pacific Veterinary Therapeutics Market Value (USD billion),by Route of Administration, 2025 & 2034

Figure 32: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025

Figure 33: Asia Pacific Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 34: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 35: Asia Pacific Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Latin America Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034

Figure 38: Latin America Veterinary Therapeutics Market Value Share (%), by Product, 2025

Figure 39: Latin America Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034

Figure 40: Latin America Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025

Figure 41: Latin America Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 42: Latin America Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025

Figure 43: Latin America Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 44: Latin America Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 45: Latin America Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025

Figure 47: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034

Figure 48: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Product, 2025

Figure 49: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034

Figure 50: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025

Figure 51: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 52: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025

Figure 53: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 54: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 55: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Veterinary Therapeutics Market Share (%), By Company, 2025

List of Tables

Table 1: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 2: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021–2034

Table 3: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021–2034

Table 4: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021–2034

Table 5: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021–2034

Table 6: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021–2034

Table 7: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021–2034

Table 8: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021–2034

Table 9: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 10: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 11: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 12: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021–2034

Table 13: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021–2034

Table 14: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021–2034

Table 15: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021–2034

Table 16: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021–2034

Table 17: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021–2034

Table 18: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021–2034

Table 19: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 20: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 21: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 22: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021–2034

Table 23: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021–2034

Table 24: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021–2034

Table 25: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021–2034

Table 26: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021–2034

Table 27: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021–2034

Table 28: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021–2034

Table 29: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 30: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 31: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 32: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021–2034

Table 33: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021–2034

Table 34: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021–2034

Table 35: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021–2034

Table 36: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021–2034

Table 37: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021–2034

Table 38: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021–2034

Table 39: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 40: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 41: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 42: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021–2034

Table 43: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021–2034

Table 44: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021–2034

Table 45: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021–2034

Table 46: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021–2034

Table 47: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021–2034

Table 48: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021–2034

Table 49: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 50: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 51: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 52: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021–2034

Table 53: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021–2034

Table 54: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021–2034

Table 55: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021–2034

Table 56: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021–2034

Table 57: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021–2034

Table 58: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021–2034

Table 59: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 60: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 210

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com